FDA approves Monjuvi (tafasitamab) for relapsed follicular lymphoma, offering hope with improved progression-free survival in ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

Tranexamic acid may lighten dark skin patches due to melasma and other skin conditions. Learn about the benefits, risks, and ...

The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.